Mu-type opioid receptor
Also known as: Oprm1, Ror-b
Function
Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Also activated by enkephalin peptides, such as Met-enkephalin or Met-enkephalin-Arg-Phe, with higher affinity for Met-enkephalin-Arg-Phe. Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G protein complex and subsequent exchange of GDP for GTP in the G protein alpha subunit leading to dissociation of the G protein complex with the free GTP-bound G protein alpha and the G protein beta-gamma dimer activating downstream cellular effectors. The agonist- and cell type-specific activity is predominantly coupled to pertussis toxin-sensitive G(i) and G(o) G alpha proteins, GNAI1, GNAI2, GNAI3 and GNAO1 isoforms Alpha-1 and Alpha-2, and to a lesser extent to pertussis toxin-insensitive G alpha proteins GNAZ and GNA15. They mediate an array of downstream cellular responses, including inhibition of adenylate cyclase activity and both N-type and L-type calcium channels, activation of inward rectifying potassium channels, mitogen-activated protein kinase (MAPK), phospholipase C (PLC), phosphoinositide/protein kinase (PKC), phosphoinositide 3-kinase (PI3K) and regulation of NF-kappa-B. Also couples to adenylate cyclase stimulatory G alpha proteins. The selective temporal coupling to G proteins and subsequent signaling can be regulated by RGSZ proteins, such as RGS9, RGS17 and RGS4. Phosphorylation by members of the GPRK subfamily of Ser/Thr protein kinases and association with beta-arrestins is involved in short-term receptor desensitization. Beta-arrestins associate with the GPRK-phosphorylated receptor and uncouple it from the G protein thus terminating signal transduction. The phosphorylated receptor is internalized through endocytosis via clathrin-coated pits which involves beta-arrestins. The activation of the ERK pathway occurs either in a G protein-dependent or a beta-arrestin-dependent manner and is regulated by agonist-specific receptor phosphorylation. Acts as a class A G protein-coupled receptor (GPCR) which dissociates from beta-arrestin at or near the plasma membrane and undergoes rapid recycling. Receptor down-regulation pathways are varying with the agonist and occur dependent or independent of G protein coupling. Endogenous ligands induce rapid desensitization, endocytosis and recycling. Heterooligomerization with other GPCRs can modulate agonist binding, signaling and trafficking properties.
Classification
- Family (Pfam)
- PF00001 7tm_1
- InterPro
- GPCR_Rhodpsn, GPCR_Rhodpsn_7TM, Mu_opioid_rcpt, Opioid_rcpt
- Functional cluster
- Membrane Transporters & GPCRs
Gene Ontology · 63
- GO:0030424 axon
- GO:0030425 dendrite
- GO:0032839 dendrite cytoplasm
- GO:0032590 dendrite membrane
- GO:0005768 endosome
- GO:0005925 focal adhesion
- GO:0098982 GABA-ergic synapse
- GO:0016020 membrane
- GO:0005739 mitochondrion
- GO:0043005 neuron projection
- GO:0043204 perikaryon
- GO:0005886 plasma membrane
- GO:0045211 postsynaptic membrane
- GO:0042734 presynaptic membrane
- GO:0042383 sarcolemma
- GO:0016529 sarcoplasmic reticulum
- GO:0097444 spine apparatus
- GO:0030315 T-tubule
- GO:0004979 beta-endorphin receptor activity
- GO:0004985 G protein-coupled opioid receptor activity
- GO:0004930 G protein-coupled receptor activity
- GO:0001965 G-protein alpha-subunit binding
- GO:0031681 G-protein beta-subunit binding
- GO:0038047 morphine receptor activity
- GO:0042923 neuropeptide binding
- GO:0019904 protein domain specific binding
- GO:0005245 voltage-gated calcium channel activity
- GO:0002438 acute inflammatory response to antigenic stimulus
- GO:0007191 adenylate cyclase-activating dopamine receptor signaling pathway
- GO:0007197 adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway
- GO:0007193 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- GO:0031635 adenylate cyclase-inhibiting opioid receptor signaling pathway
- GO:0048149 behavioral response to ethanol
- GO:0042755 eating behavior
- GO:0044849 estrous cycle
- GO:0060079 excitatory postsynaptic potential
- GO:0038003 G protein-coupled opioid receptor signaling pathway
- GO:0007186 G protein-coupled receptor signaling pathway
- GO:0006955 immune response
- GO:0007626 locomotory behavior
- GO:0106072 negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway
- GO:0051481 negative regulation of cytosolic calcium ion concentration
- GO:0033685 negative regulation of luteinizing hormone secretion
- GO:0045019 negative regulation of nitric oxide biosynthetic process
- GO:0061358 negative regulation of Wnt protein secretion
- GO:0007218 neuropeptide signaling pathway
- GO:0007200 phospholipase C-activating G protein-coupled receptor signaling pathway
- GO:0032100 positive regulation of appetite
- GO:0070374 positive regulation of ERK1 and ERK2 cascade
- GO:0045722 positive regulation of gluconeogenesis
- GO:0050769 positive regulation of neurogenesis
- GO:0099171 presynaptic modulation of chemical synaptic transmission
- GO:0080135 regulation of cellular response to stress
- GO:2000310 regulation of NMDA receptor activity
- GO:0042220 response to cocaine
- GO:0045471 response to ethanol
- GO:0032094 response to food
- GO:0070848 response to growth factor
- GO:0032496 response to lipopolysaccharide
- GO:0019233 sensory perception of pain
- GO:0035176 social behavior
- GO:0042713 sperm ejaculation
- GO:0019226 transmission of nerve impulse
Neighborhood · nearest proteins
Related proteins · sequence + function similarity
- Mu-type opioid receptor 1.00
- Mu-type opioid receptor 0.99
- Mu-type opioid receptor 0.99
- Mu-type opioid receptor 0.99
- Mu-type opioid receptor 0.99
- Mu-type opioid receptor 0.99
- Mu-type opioid receptor 0.99
- Mu-type opioid receptor 0.99
- Kappa-type opioid receptor 0.96
- Kappa-type opioid receptor 0.96
- Kappa-type opioid receptor 0.96
- Kappa-type opioid receptor 0.95
Co-cited proteins · studied together in the literature
- Delta-type opioid receptor 1 shared papers
- Mu-type opioid receptor 2 shared papers
- Mu-type opioid receptor 1 shared papers
- Neuronal membrane glycoprotein M6-a 1 shared papers
- Proenkephalin-A 1 shared papers
Literature · 41 cited papers
- Modulating micro-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKCepsilon activation and dendritic spine stability. J. Biol. Chem. · 2011
- Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy. Mol. Pharmacol. · 2010
- Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling. Cell. Signal. · 2009
- Morphine-induced mu-opioid receptor rapid desensitization is independent of receptor phosphorylation and beta-arrestins. Cell. Signal. · 2008
- Beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) Translocate to Nucleus in Contrast to G protein-dependent ERK activation. Mol. Pharmacol. · 2008
- Membrane glycoprotein M6a interacts with the micro-opioid receptor and facilitates receptor endocytosis and recycling. J. Biol. Chem. · 2007
- Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. FASEB J. · 2007
- Interaction of the mu-opioid receptor with synaptophysin influences receptor trafficking and signaling. Mol. Pharmacol. · 2007
- mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br. J. Pharmacol. · 2006
- Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes. J. Biol. Chem. · 2005
- Biochemical demonstration of mu-opioid receptor association with Gsalpha: enhancement following morphine exposure. Brain Res. Mol. Brain Res. · 2005
- Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy. J. Neurochem. · 2004
- … and 29 more in the literature graph